| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 01/27/2009 | US7482372 Antiinflammatory; cartilage protecting therapeutics; antiarthritic agent; N-{4-[(2-methyl-4-quinolinyl)methoxy]phenyl}-2,4-dioxo-1,3-diazaspiro[4.5]decane-6-carboxamide; 2-(2,5-dioxo-4-imidazolidinyl)-N-{4-[(2-methyl-4-quinolinyl)methoxy]phenyl)acetamide |
| 01/27/2009 | US7482369 Anthranilic acid amides and their use as VEGF receptor tyrosine kinase inhibitors |
| 01/27/2009 | US7482365 Piperidylcarboxamide derivatives and their use in the treatment of tachykinin-mediated diseases |
| 01/27/2009 | US7482363 N-[[4-(2-Chloro-4-fluorophenoxy)[1,4'-bipiperidin]-1'-yl]carbonyl]-4-methyl benzenesulfonamide, used for prophylaxis of respiratory system disorders or as antiallergens |
| 01/27/2009 | US7482342 Indazolecarboxamide derivatives, preparation and use thereof as CDK1, CDK2 and CDK4 inhibitors |
| 01/27/2009 | US7482325 Downregulation of immune response by administering B7RP-2 fusion protein |
| 01/27/2009 | US7482024 highly dispersible mixture of drugs and dipeptides or tripeptides, in the form of liquids, aerosols or powders, administered by inhalation |
| 01/27/2009 | US7482013 Albumin fusion proteins |
| 01/27/2009 | US7482012 Streptococcus pyogenes polypeptides and corresponding DNA fragments |
| 01/27/2009 | US7482007 Methods of inhibiting angiogenesis to treat cancer with alphavbeta3-specific antibodies |
| 01/27/2009 | US7482003 Also for treatment of inflammatory bowel disease; humanized heavy/light chains; complementary determining regions |
| 01/27/2009 | CA2416403C A medicinal aerosol formulation |
| 01/27/2009 | CA2391871C Anti-inflammatory oxo derivatives and hydroxy derivatives of pyrrolizines, and their pharmaceutical use |
| 01/27/2009 | CA2388646C Methods and compositions utilizing quinazolinones |
| 01/27/2009 | CA2361605C Pyrimidine-2,4,6-triones as inhibitors of matrix metalloproteinases |
| 01/27/2009 | CA2360248C Combinations of formoterol and a tiotropium salt |
| 01/27/2009 | CA2309653C Use of protein h as cytostatic agent |
| 01/27/2009 | CA2290520C Inhibition of p38 kinase activity by aryl ureas |
| 01/27/2009 | CA2283071C Serine proteinase inhibitory activity by hydrophobic tetracycline |
| 01/27/2009 | CA2264028C A stable ointment containing acetyl salicylic acid |
| 01/22/2009 | WO2009012425A2 Compositions including leukotriene antagonists and nsaids and methods of using the same |
| 01/22/2009 | WO2009012259A1 Pentafluorosulfanyl-substituted piperazinylpiperidine derivatives as chemokine receptor antagonists |
| 01/22/2009 | WO2009012156A2 Treatments and diagnostics for cancer, inflammatory disorders and autoimmune disorders |
| 01/22/2009 | WO2009011871A2 Thiadiazole modulators of pkb |
| 01/22/2009 | WO2009010824A1 Dihydrochromenopyrazole derivatives as vanilloid receptor ligands |
| 01/22/2009 | WO2009010791A2 Cyclic ethers |
| 01/22/2009 | WO2009010529A1 Synergistic combinations of vr-1 antagonists and cox-2 inhibitors |
| 01/22/2009 | WO2009010491A1 6-phenyl-1h-imidazo[4,5-c]pyridine-4-carbonitrile derivatives as cathepsin inhibitors |
| 01/22/2009 | WO2009010488A1 Heterocyclic compounds useful as mk2 inhibitors |
| 01/22/2009 | WO2009010478A2 Use of piperidine derivatives as agonists of chemokine receptor activity |
| 01/22/2009 | WO2009010477A1 Piperidine-4-acetic acid derivatives and their use |
| 01/22/2009 | WO2008142550A3 Spirocyclic quinazoline derivatives and their use as pde7 inhibitors |
| 01/22/2009 | WO2008125600A3 Pyrazole derivatives as p2x7 modulators |
| 01/22/2009 | US20090023900 Anti-AlphaVBeta3 Recombinant Human Antibodies, Nucleic Acids Encoding Same |
| 01/22/2009 | US20090023810 Methods of translation and/or inflammation blockade |
| 01/22/2009 | US20090023795 Kinase Inhibitors And Methods Of Use Thereof |
| 01/22/2009 | US20090023791 PH-dependent NMDA receptor antagonists |
| 01/22/2009 | US20090023789 N-[(5Z)-4-butyl-2-tert-butylisothiazol-5(2H)-ylidene]-5-chloro-2-methoxybenzamide; CB2 receptors ligand; antiinflammatory, analgesic agent; autoimmune diseases; neuroprotectants |
| 01/22/2009 | US20090023770 1-methoxy-2-methyl-3-[(4-nitrophenyl)sulphonyl]indolizine, used as angiogenesis inhibitors |
| 01/22/2009 | US20090023763 Condensed Pyridine Derivatives Useful as A2B Adenosine Receptor Antagonists |
| 01/22/2009 | US20090023761 Heterocyclic compounds and their uses |
| 01/22/2009 | US20090023749 Crystal structure; antidepressants; anxiolytic agents; eating disorders; bipolar disorders; Alzheimer's disease; sleep disorders; psychiatric disorders; sexual dysfunctions; fibromyalgia |
| 01/22/2009 | US20090023742 Thiazolones for use as pi3 kinase inhibitors |
| 01/22/2009 | US20090023739 Capase inhibitors and uses thereof |
| 01/22/2009 | US20090023735 Sulphonamide Derivatives |
| 01/22/2009 | US20090023732 Citrate Salt of an Indole Derivative and its Pharmaceutical Use |
| 01/22/2009 | US20090023724 Heteroaryl compounds, compositions thereof, and methods of treatment therewith |
| 01/22/2009 | US20090023676 RNA Interference Mediated Inhibition of MAP Kinase Gene Expression or Expression of Genes Involved in MAP Kinase Pathway Using Short Interfering Nucleic Acid (SiNA) |
| 01/22/2009 | US20090023675 RNA Interference Mediated Inhibition of Gene Expression Using Chemically Modified Short Interfering Nucleic Acid (siNA) |
| 01/22/2009 | US20090023668 Method for treating blepharitis |
| 01/22/2009 | US20090023663 Thymosin beta 4 compositions and methods |
| 01/22/2009 | US20090023659 Using cell surface adhesion proteins specific immunoglobulin to target therapeutics to tumorous; immunodiagnostics; immunotherapy |
| 01/22/2009 | US20090023649 for treating diseases relating to angiogenesis; fusion protein possesses ribosome inactivating activity and ability to bind to cellular vascular endothelial growth factor (VEGF) receptors |
| 01/22/2009 | US20090023224 Vascular endothelial growth factor 2 |
| 01/22/2009 | US20090023216 Double-Stranded Oligonucleotides |
| 01/22/2009 | US20090022815 Halogenated composition, method for preparing same and uses thereof |
| 01/22/2009 | US20090022801 Compositions and Methods for Promoting the Healing of Tissue of Multicellular Organisms |
| 01/22/2009 | US20090022743 Peptides Effective in the Treatment of Tumors and Other Conditions Requiring the Removal or Destruction of Cells |
| 01/22/2009 | US20090022724 Attractin/mahogany-like polypeptides, polynucleotides, antibodies and methods of use thereof |
| 01/22/2009 | US20090022723 Anti-il-tif antibodies and methods of using in inflammation |
| 01/22/2009 | US20090022712 Compositions and Methods for Inhibiting Leukocyte Function |
| 01/22/2009 | US20090022707 contacting target cells with a therapeutic quantity of a soluble antibody that specifically binds tumor necrosis factor-related apoptosis inducing ligand receptor(TRAIL) DR5, and contacting target cells with a therapeutic agent |
| 01/22/2009 | US20090022704 Method for the treatment of gout or pseudogout |
| 01/22/2009 | US20090022686 Pharmaceutical compositions for the treatment of systemic inflammatory response syndrome |
| 01/22/2009 | CA2696833A1 Disease treatment via antimicrobial peptides or their inhibitors |
| 01/22/2009 | CA2693904A1 Heterocyclic compounds useful as mk2 inhibitors |
| 01/22/2009 | CA2693887A1 6-phenyl-1h-imidazo[4,5-c]pyridine-4-carbonitrile derivatives as cathepsin inhibitors |
| 01/22/2009 | CA2693473A1 Thiadiazole modulators of pkb |
| 01/22/2009 | CA2692655A1 Synergistic combinations of vr-1 antagonists and cox-2 inhibitors |
| 01/22/2009 | CA2691847A1 Treatments and diagnostics for cancer, inflammatory disorders and autoimmune disorders |
| 01/21/2009 | EP2017343A2 Protein A based binding domains with desirable activities |
| 01/21/2009 | EP2017337A1 Human tumor necrosis factor receptors |
| 01/21/2009 | EP2017266A1 Pyridazine derivatives and medicines containing the same as effective ingredients |
| 01/21/2009 | EP2016953A2 Vascular endothelial cell growth factor antagonists and uses thereof |
| 01/21/2009 | EP2016944A2 Angiogenesis inhibitor containing a derivative of rifampicin |
| 01/21/2009 | EP2016063A1 Thiazole derivatives as inhibitors of p13 kinase |
| 01/21/2009 | EP2016055A1 Inhibitors of p38 map kinase |
| 01/21/2009 | EP1924580B1 Non-steroidal compounds useful as glucocorticoid receptor modulators |
| 01/21/2009 | EP1626964B1 New benzimidazole derivatives |
| 01/21/2009 | EP1613315B1 Quinoline-2-one-derivatives for the treatment of airways diseases |
| 01/21/2009 | EP1549619B1 4-aminobenzofuran compounds as phosphodiesterase 4 inhibitors |
| 01/21/2009 | EP1509523B1 Triazaspiro compounds useful for treating or preventing pain |
| 01/21/2009 | EP1487273B1 Compositions and methods for treatment of microbial infections |
| 01/21/2009 | EP1353691B1 Molecular antigen array presenting amyloid beta |
| 01/21/2009 | CN101351453A 杂环酰胺化合物及其用途 The heterocyclic amide compounds and use thereof |
| 01/21/2009 | CN101351445A Bicyclic heteroyclic compounds as antiinflammatory or antiallergic agents |
| 01/21/2009 | CN101351200A Methods for reducing the amount of proinflammatory substance in animal tissue or body fluid |
| 01/21/2009 | CN101348516A Refining process of triamcinolone acetonide raw medicine |
| 01/21/2009 | CN101348455A Aspartic acid specificity cysteine proteinase inhibitors and uses thereof |
| 01/21/2009 | CN101348439A 6-substituted aryl -2-naphthoic acid derivative and preparation thereof |
| 01/21/2009 | CN101348433A 4-alkoxy-coumarin fatty acid ester, synthetic method and use |
| 01/21/2009 | CN101347623A Multifunctional nanodevice platform |
| 01/21/2009 | CN101347606A Chinese medicine plaster for treating rheumatism osteonosus |
| 01/21/2009 | CN101347600A Chinese medicine for treating swelling pain of head |
| 01/21/2009 | CN101347598A Liniment spray for bonesetting and pain-alleviating |
| 01/21/2009 | CN101347595A Chinese medicine for treating rheumatic heart of children |
| 01/21/2009 | CN101347585A Powder medicine for gynaecologic abnormal menstruation and leukorrhea, and palsy |
| 01/21/2009 | CN101347582A Chinese medicinal composition for dispelling wind and freeing collateral vessels, strengthening muscles and bones, and preparation method thereof |
| 01/21/2009 | CN101347577A Medicated wine for treating rheumatalgia |
| 01/21/2009 | CN101347568A Formulation of yam pills and quality control method |